Abstract
Purpose
Lacunar infarcts are thought to result from occlusion of small penetrating arteries due to microatheroma and lipohyalinosis, pathognomonic for cerebral small vessel disease (CSVD). Concurrent embolic ischemic lesions indicate a different stroke mechanism. The purpose of this study was to examine the clinical characteristics and outcome of patients with lacunar infarcts and concurrent embolic infarcts on diffusion-weighted imaging (DWI).
Methods
All patients screened for the WAKE-UP trial (ClinicalTrials.gov number, NCT01525290) were reviewed for acute lacunar infarcts and concurrent embolic lesions on baseline DWI. Clinical characteristics and outcome were compared between lacunar infarct patients with and without concurrent embolic lesions.
Results
Of 244 patients with an acute lacunar infarct, 20 (8.2%) had concurrent acute embolic infarcts. Compared to patients with a lacunar infarct only, patients with concurrent embolic infarcts were older (mean age 69 years vs. 63 years; p = 0.031), more severely affected (median National Institutes of Health Stroke Scale [NIHSS] score 5 vs. 4; p = 0.046), and—among those randomized—had worse functional outcome at 90 days (median modified Rankin Scale [mRS] 3 vs. 1; p = 0.011).
Conclusion
Approximately 8% of lacunar infarct patients show concurrent embolic lesions suggesting a stroke etiology other than CSVD. These patients are more severely affected and have a worse functional outcome illustrating the need for a thorough diagnostic work-up of possible embolic sources even in patients with an imaging-defined diagnosis of lacunar infarcts.
Similar content being viewed by others
References
Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997;28:491–9.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, nEuroimaging STfRVco. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38.
Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology. 1965;15:774–84.
Caso V, Budak K, Georgiadis D, Schuknecht B, Baumgartner RW. Clinical significance of detection of multiple acute brain infarcts on diffusion weighted magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2005;76:514–8.
Takahashi K, Kobayashi S, Matui R, Yamaguchi S, Yamashita K. The differences of clinical parameters between small multiple ischemic lesions and single lesion detected by diffusion-weighted MRI. Acta Neurol Scand. 2002;106:24–9.
Ay H, Oliveira-Filho J, Buonanno FS, Ezzeddine M, Schaefer PW, Rordorf G, Schwamm LH, Gonzalez RG, Koroshetz WJ. Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke. 1999;30:2644–50.
Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, Cheripelli B, Cho TH, Fazekas F, Fiehler J, Ford I, Galinovic I, Gellissen S, Golsari A, Gregori J, Gunther M, Guibernau J, Hausler KG, Hennerici M, Kemmling A, Marstrand J, Modrau B, Neeb L, Perez de la Ossa N, Puig J, Ringleb P, Roy P, Scheel E, Schonewille W, Serena J, Sunaert S, Villringer K, Wouters A, Thijs V, Ebinger M, Endres M, Fiebach JB, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Gerloff C, WAKE-UP Investigators. MRI-guided Thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018;379:611–22. https://doi.org/10.1056/NEJMoa1804355
von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD, Treurniet KM, Majoie CB, Marquering HA, Mazya MV, San Román L, Saver JL, Strbian D, Whiteley W, Hacke W. The Heidelberg bleeding classification: classification of bleeding events after Ischemic stroke and Reperfusion therapy. Stroke. 2015;46:2981–6.
Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol. 2003;2:238–45.
Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol. 1979;36:65–73.
Laloux P, Brucher JM. Lacunar infarctions due to cholesterol emboli. Stroke. 1991;22:1440–4.
Futrell N, Millikan C, Watson BD, Dietrich WD, Ginsberg MD. Embolic stroke from a carotid arterial source in the rat: pathology and clinical implications. Neurology. 1989;39:1050–6.
Macdonald RL, Kowalczuk A, Johns L. Emboli enter penetrating arteries of monkey brain in relation to their size. Stroke. 1995;26:1247–50. discussion 50–1.
Futrell N. Lacunar infarction: embolism is the key. Stroke. 2004;35:1778–9.
Kang DW, Chalela JA, Ezzeddine MA, Warach S. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch Neurol. 2003;60:1730–4.
Chowdhury D, Wardlaw JM, Dennis MS. Are multiple acute small subcortical infarctions caused by embolic mechanisms? J Neurol Neurosurg Psychiatry. 2004;75:1416–20.
Seifert T, Enzinger C, Storch MK, Pichler G, Niederkorn K, Fazekas F. Acute small subcortical infarctions on diffusion weighted MRI: clinical presentation and aetiology. J Neurol Neurosurg Psychiatry. 2005;76:1520–4.
Del Bene A, Makin SD, Doubal FN, Inzitari D, Wardlaw JM. Variation in risk factors for recent small subcortical infarcts with infarct size, shape, and location. Stroke. 2013;44:3000–6.
Simonsen CZ, Sørensen LH, Karabegovic S, Mikkelsen IK, Schmitz ML, Juul N, Yoo AJ, Andersen G. MRI before intraarterial therapy in ischemic stroke: feasibility, impact, and safety. J Cereb Blood Flow Metab. 2014;34:1076–81.
Parody E, Pedraza S, García-Gil MM, Crespo C, Serena J, Dávalos A. Cost-utility analysis of magnetic resonance imaging management of patients with acute Ischemic stroke in a Spanish hospital. Neurol Ther. 2015;4:25–37.
Funding
The WAKE-UP trial received funding from the European Union Seventh Framework Program (FP7/2007–2013) under grant agreement n°278276 (WAKE-UP).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
E. Barow received grants from the European Union 7th Framework Program during the conduct of the study and grants from the German Parkinson Society and ACTELION Pharmaceuticals Deutschland GmbH, outside the submitted work. F. Boutitie received grants from the University Medical Center Hamburg-Eppendorf during the conduct of the study. M. Ebinger received grants from the European Union 7th Framework Program during the conduct of the study. M. Endres received grants from European Union 7th Framework Program during the conduct of the study, grants from the Bayer and fees paid to the Charité from Bayer, Boehringer Ingelheim, BMS/Pfizer, Daiichi Sankyo, Amgen, GlaxoSmithKlineGSK, Sanofi, Covidien, Ever, Novartis, all outside the submitted work. J.B. Fiebach received grants from the European Union 7th Framework Program during the conduct of the study and personal fees from Bioclinica, Artemida, Cerevast, and Nicolab outside the submitted work. I. Galinovic received grants from the European Union 7th Framework Program during the conduct of the study. A. Nickel received grants from European Union 7th Framework Program during the conduct of the study. P. Roy received grants from the European Union 7th Framework Program during the conduct of the study. V. Thijs received grants from the European Union 7th Framework Program and personal fees and non-financial support from Boehringer Ingelheim, Pfizer/BMS, Bayer, Sygnis, Amgen and Allergan outside the submitted work. K.W. Muir received grants from the European Union 7th Framework Program during the conduct of the study, personal fees and non-financial support from Boehringer Ingelheim outside the submitted work. S. Pedraza received grants from the European Union 7th Framework Program during the conduct of the study. C.Z. Simonsen received grants from Novo Nordisk Foundation and personal fees from Bayer outside the submitted work. C. Gerloff received from the European Union 7th Framework Program during the conduct of the study, personal fees from AMGEN, Bayer Vital, BMS, Boehringer Ingelheim, Sanofi Aventis, Abbott, and Prediction Biosciences outside the submitted work. G. Thomalla received grants from the European Union 7th Framework Program during the conduct of the study, personal fees from Acandis, Boehringer Ingelheim, BMS/Pfizer, Stryker, Daiichi Sankyo, grants and personal fees from Bayer, grants from Corona Foundation, German Innovation Fonds and Else Kroener Fresenius Foundation outside the submitted work. B. Cheng, T.-H. Cho, J. Fiehler, I. Ford, J. Puig, A. Wouters, R. Lemmens and N. Nighoghossian declare that they have no competing interests.
Caption Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Barow, E., Boutitie, F., Cheng, B. et al. Clinical Characteristics and Outcome of Patients with Lacunar Infarcts and Concurrent Embolic Ischemic Lesions. Clin Neuroradiol 30, 511–516 (2020). https://doi.org/10.1007/s00062-019-00800-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-019-00800-5